cbdMD, Inc.
YCBD · AMEX
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -19.3% | -31.8% | -20.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.6% | 62% | 63.1% | 67.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7.7% | -82.8% | -43.7% | -49.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -19% | -95% | -209.3% | -52.6% |
| EPS Diluted | -1.79 | -13.32 | -55.8 | -19.16 |
| % Growth | 86.6% | 76.1% | -191.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |